awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36106412-6BB7C69C-2493-4828-BD33-209D920F09E7
Q36106412-6BB7C69C-2493-4828-BD33-209D920F09E7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36106412-6BB7C69C-2493-4828-BD33-209D920F09E7
A phase 1 study of a heterologous prime-boost vaccination involving a truncated HER2 sequence in patients with HER2-expressing breast cancer.
P2860
Q36106412-6BB7C69C-2493-4828-BD33-209D920F09E7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36106412-6BB7C69C-2493-4828-BD33-209D920F09E7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7ca3f58dfaff4446a572b762676a30a8d5e7665d
P2860
Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease.